Single Technology Appraisals (STAs)
STAs evaluate single technologies within a single condition. The company provides a submission detailing the clinical effectiveness and estimating the cost-effectiveness of the intervention.
Off
SCHARR-TAG critiques the company’s submission and mathematical model and provides the NICE appraisal committee with exploratory analyses and corresponding cost-effectiveness values.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009
2024
.
.
.
.
.
.
.
.
.
.
.
.
.
.
2023
.
.
.
.
.
.
2022
.
.
.
.
.
.
.
.
2021
.
.
.
.
.
.
.
.
2020
.
.
.
.
.
.
.
.
.
2019
.
.
.
.
.
.
.
2018
.
.
.
.
2017
.
.
.
2016
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
2015
.
2014
.
.
.
2013
.
.
2012
.
.
.
.
.
.
.
2011
.
.
2010
.
.
2009
.
.
.
.
.
.